Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis.

Rheumatology international - 1 Sept 2009

Wagner Ernst, Skoumal M, Bayer P M, Klaushofer K

Abstract excerpt

The aim of this study was to determine the performance of antibodies against mutated citrullinated vimentin (anti-MCV) in comparison with antibodies to cyclic citrullinated peptides (anti-CCP) in patients with rheumatoid arthritis (RA). Serum levels of anti-MCV and anti-CCP were determined in 193 patients with RA and 332 controls, and sensitivity and specificity were calculated. In a separate analysis of 86...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arthritis, Rheumatoid
Share to Autoantibodies
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Citrulline

Share to Peptides, Cyclic

Share to Sensitivity and Specificity

Share to Sex Characteristics

Share to Vimentin

Source

Identifiers

PMID: 19184032
DOI: 10.1007/s00296-009-0854-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis.PMID 19184032Read ↗

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy.Semantic proximity Read ↗

Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis.Semantic proximity Read ↗

Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis.Semantic proximity Read ↗

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.Semantic proximity Read ↗

Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis.Semantic proximity Read ↗

The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.Semantic proximity Read ↗

Mutated citrullinated vimentin antibodies in rheumatoid arthritis.Semantic proximity Read ↗

Antibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis.Semantic proximity Read ↗

Anti-mutated citrullinated vimentin antibody and rheumatoid factor (prevalence and association) in rheumatoid arthritis patients; Saudi and non-Saudi.Semantic proximity Read ↗

Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis.Semantic proximity Read ↗

Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.Semantic proximity Read ↗

Evaluation of the clinical performance of anti-mutated citrullinated vimentin antibody and 14-3-3 eta testing in rheumatoid arthritis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.